MedPath

Effectiveness of High Intensity Interval Training (HIIT) on Improving Cardiometabolic Health After SCI

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Metabolic Syndrome
Interventions
Other: High Intensity Interval Training
Registration Number
NCT03808363
Lead Sponsor
Brock University
Brief Summary

Testing the efficacy of high intensity interval training (HIIT), as compared to current research supporting moderate intensity continuous training (MICT), as a means to improve cardiometabolic health after spinal cord injury.

Detailed Description

This study aims to challenge the effectiveness of the current aerobic exercise recommendations for individuals with spinal cord injuries (SCI). Currently, moderate intensity continuous training (MICT) is suggested however this study intends to explore the effectiveness of high intensity interval training (HIIT). To do so, approximately 8 individuals with SCI will be undergo a 6 week HIIT intervention consisting of 3 sessions per week. With a focus on cardiometabolic health markers (listed in outcome measure section), we aim to provide support for HIIT as a viable method of mitigating cardiovascular risk in a SCI population.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
8
Inclusion Criteria
  • Individuals with a spinal cord injury (paraplegia or tetraplegia, complete or incomplete) who are at least one-year post injury.
  • Declared medically stable, and able to communicate clearly in English.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
High Intensity Interval Training GroupHigh Intensity Interval TrainingApproximately eight individuals with spinal cord injuries will participate in high intensity interval training for 6 weeks
Primary Outcome Measures
NameTimeMethod
Pulse Wave Velocity6 weeks

Arterial stiffness, a common measure for cardiac risk will be measured

Waist circumference (inches)6 weeks

Central adiposity will be measured by tape measure to monitor possible weight loss

Cholesterol6 weeks

Total and HDL cholesterol will be measured in serum

Triglycerides6 weeks

Triglycerides will be measured in serum

Glycated Hemoglobin (HbA1c)6 weeks

Glycated hemoglobin will be measured in whole blood as an indicator of diabetic risk

Tumor necrosis factor (TNF-a)6 weeks

TNF-a will be used as an inflammatory representative and will be measured in serum

Interleukin - 10 (IL-10)6 weeks

IL-10 will will be used as an anti-inflammatory representative and will be measured in serum

Adiponectin6 weeks

Adiponectin will will be used as a surrogate for insulin resistance and will be measured in serum

Blood pressure6 weeks

Measured through a digital cuff, the focus will be on both systolic and diastolic

Peak Oxygen Consumption (VO2 peak)6 weeks

VO2 peak will be measured by a Moxus metabolic cart to determine changes in fitness

C Reactive Protein (CRP)6 weeks

CRP will will be used as an inflammatory representative and will be measured in serum

Leptin6 weeks

Leptin will will be used as a body fat representative and will be measured in serum

Secondary Outcome Measures
NameTimeMethod
Physical Activity Enjoyment Scale (PACES)6 weeks

All participants will complete the physical activity enjoyment scale (PACES) to indicate enjoyment of HIIT. With a total of 18 questions, options 1 through 7 going from a positive to a negative overall experience with the HIIT protocol will be documented.

Trial Locations

Locations (1)

Brock University

🇨🇦

St. Catherines, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath